Wealth Group Ltd Invests $231,000 in The Clorox Company (NYSE:CLX)

Wealth Group Ltd purchased a new stake in shares of The Clorox Company (NYSE:CLX) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm purchased 1,417 shares of the company’s stock, valued at approximately $231,000.

Several other institutional investors have also recently bought and sold shares of CLX. Jacobi Capital Management LLC raised its holdings in shares of Clorox by 10.9% in the fourth quarter. Jacobi Capital Management LLC now owns 8,415 shares of the company’s stock valued at $1,200,000 after buying an additional 830 shares during the last quarter. Garner Asset Management Corp bought a new position in shares of Clorox in the fourth quarter worth about $97,000. Bridgefront Capital LLC acquired a new position in shares of Clorox during the fourth quarter worth approximately $351,000. Bontempo Ohly Capital Mgmt LLC grew its stake in shares of Clorox by 3.8% during the fourth quarter. Bontempo Ohly Capital Mgmt LLC now owns 27,649 shares of the company’s stock valued at $3,942,000 after purchasing an additional 1,004 shares during the last quarter. Finally, Parsifal Capital Management LP acquired a new stake in shares of Clorox in the fourth quarter valued at approximately $128,245,000. Institutional investors own 78.53% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on CLX. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and upped their price objective for the stock from $174.00 to $187.00 in a report on Tuesday, October 1st. JPMorgan Chase & Co. cut their price target on Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Wells Fargo & Company lowered their price objective on Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Deutsche Bank Aktiengesellschaft upped their target price on shares of Clorox from $144.00 to $151.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Finally, Barclays lifted their price target on shares of Clorox from $122.00 to $130.00 and gave the stock an “underweight” rating in a research report on Monday, August 5th. Six investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company. According to MarketBeat, Clorox currently has an average rating of “Hold” and an average target price of $146.13.

Insider Buying and Selling at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.51% of the company’s stock.

Clorox Trading Down 0.2 %

NYSE:CLX opened at $159.53 on Thursday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The business’s 50-day simple moving average is $156.55 and its 200-day simple moving average is $144.65. The Clorox Company has a fifty-two week low of $114.68 and a fifty-two week high of $169.09. The stock has a market capitalization of $19.81 billion, a PE ratio of 82.66, a price-to-earnings-growth ratio of 3.31 and a beta of 0.41.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The firm had revenue of $1.90 billion for the quarter, compared to analyst estimates of $1.97 billion. Sell-side analysts expect that The Clorox Company will post 6.63 earnings per share for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 7th. Shareholders of record on Wednesday, October 23rd will be issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 3.06%. The ex-dividend date of this dividend is Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.